Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Glucose 6-P dehydrogenase delays the onset of frailty by protecting against muscle damage

  • Arc-Chagnaud, Coralie
  • Salvador-Pascual, Andrea
  • Garcia-Dominguez, Esther
  • Olaso-Gonzalez, Gloria
  • Correas, Angela G.
  • Serna, Eva
  • Brioche, Thomas
  • Chopard, Angele
  • Fernandez-Marcos, Pablo J.
  • Serrano, Manuel
  • Serrano, Antonio L.
  • Muñoz Cánoves, Pura, 1962-
  • Sebastiá, Vicente
  • Viña, Jose
  • Gomez-Cabrera, Mari Carmen
Background: Frailty is a major age-associated syndrome leading to disability. Oxidative damage plays a significant role in the promotion of frailty. The cellular antioxidant system relies on reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is highly dependent on glucose 6-P dehydrogenase (G6PD). The G6PD-overexpressing mouse (G6PD-Tg) is protected against metabolic stresses. Our aim was to examine whether this protection delays frailty. Methods: Old wild-type (WT) and G6PD-Tg mice were evaluated longitudinally in terms of frailty. Indirect calorimetry, transcriptomic profile, and different skeletal muscle quality markers and muscle regenerative capacity were also investigated. Results: The percentage of frail mice was significantly lower in the G6PD-Tg than in the WT genotype, especially in 26-month-old mice where 50% of the WT were frail vs. only 13% of the Tg ones (P < 0.001). Skeletal muscle transcriptomic analysis showed an up-regulation of respiratory chain and oxidative phosphorylation (P = 0.009) as well as glutathione metabolism (P = 0.035) pathways in the G6PD-Tg mice. Accordingly, the Tg animals exhibited an increase in reduced glutathione (34.5%, P < 0.01) and a decrease on its oxidized form (-69%, P < 0.05) and in lipid peroxidation (4-HNE: -20.5%, P < 0.05). The G6PD-Tg mice also showed reduced apoptosis (BAX/Bcl2: -25.5%, P < 0.05; and Bcl-xL: -20.5%, P < 0.05), lower levels of the intramuscular adipocyte marker FABP4 (-54.7%, P < 0.05), and increased markers of mitochondrial content (COX IV: 89.7%, P < 0.05; Grp75: 37.8%, P < 0.05) and mitochondrial OXPHOS complexes (CII: 81.25%, P < 0.01; CIII: 52.5%, P < 0.01; and CV: 37.2%, P < 0.05). Energy expenditure (-4.29%, P < 0.001) and the respiratory exchange ratio were lower (-13.4%, P < 0.0001) while the locomotor activity was higher (43.4%, P < 0.0001) in the 20-month-old Tg, indicating a major energetic advantage in these mice. Short-term exercise training in young C57BL76J mice induced a robust activation of G6PD in skeletal muscle (203.4%, P < 0.05), similar to that achieved in the G6PD-Tg mice (142.3%, P < 0.01). Conclusions: Glucose 6-P dehydrogenase deficiency can be an underestimated risk factor for several human pathologies and even frailty. By overexpressing G6PD, we provide the first molecular model of robustness. Because G6PD is regulated by pharmacological and physiological interventions like exercise, our results provide molecular bases for interventions that by increasing G6PD will delay the onset of frailty., This work was supported by Instituto de Salud Carlos III CB16/10/00435 (CIBERFES) (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish Ministry of Innovation and Science; 109_RESIFIT from Fundación General CSIC; PROMETEO/2019/097 de ‘Consellería, de Sanitat de la Generalitat Valenciana’ and EU Funded H2020-DIABFRAIL-LATAM (Ref: 825546); European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL); and the ERA-NET Cofund ERA-HDHL (GA No. 696295 of the EU Horizon 2020 Research and Innovation Programme). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020). Work in the laboratory of P.J.F.-M. was funded by the FBBVA and the Ramón Areces Foundations. Work in the laboratory of P.M.-C. and A.L.S was funded by by MWRF and Fundació La Marató/TV3-80/19-202021 to P.M.C. and Fundació La Marató de TV3 (Project 202033 to A.L.S.), MINECO-Spain (RTI2018-096068), ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, and DPP-Spain; María-de-Maeztu-Program for Units of Excellence to UPF (MDM-2014-0370); and Severo-Ochoa-Program for Centers of Excellence to CNIC (SEV-2015-0505). A.S.-P. was supported by a fellowship from the Spanish ‘Ministerio de Educación, Cultura y Deporte’, award FPU 14/00098.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models

  • Costa-Machado, Luis Filipe
  • Fabregat-Safont, David
  • Pozo Mendoza, Óscar J., 1975-
  • Fernandez-Marcos, Pablo J.
Reversible and sub-lethal stresses to the mitochondria elicit a program of compensatory responses that ultimately improve mitochondrial function, a conserved anti-aging mechanism termed mitohormesis. Here, we show that harmol, a member of the beta-carbolines family with anti-depressant properties, improves mitochondrial function and metabolic parameters, and extends healthspan. Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain barrier. Mechanistically, simultaneous modulation of the targets of harmol monoamine-oxidase B and GABA-A receptor reproduces harmol-induced mitochondrial improvements. Diet-induced pre-diabetic male mice improve their glucose tolerance, liver steatosis and insulin sensitivity after treatment with harmol. Harmol or a combination of monoamine oxidase B and GABA-A receptor modulators extend the lifespan of hermaphrodite Caenorhabditis elegans or female Drosophila melanogaster. Finally, two-year-old male and female mice treated with harmol exhibit delayed frailty onset with improved glycemia, exercise performance and strength. Our results reveal that peripheral targeting of monoamine oxidase B and GABA-A receptor, common antidepressant targets, extends healthspan through mitohormesis., Work in the laboratory of P.J.F.-M. was funded by the IMDEA Food Institute, the Ramón Areces Foundation (CIVP18A3891), the AECC (SIRTBIO, LABAE18008FERN), the MICINN (SAF2017-85766-R and PRPPID2020-114077RB-I00) co-funded by the European Regional Development Fund, and a Ramon y Cajal Fellowship (MICINN, RYC-2017-22335). J.L.L.-A. was funded by the Spanish Ministry of Science and Innovation (MICINN) (PTA2017‐14689‐I). Work in FreshAge laboratory was funded by: Instituto de Salud Carlos III CB16/10/00435 (CIBERFES), (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish Ministry of Innovation and Science; FGCSIC/PSLINTERREG/FEDER; PROMETEO/2019/097 de “Consellería de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana). Support from Ramón Areces Fundation and Soria Melguizo Foundation is also acknowledged. E.G.-D. was a recipient of a predoctoral grant financed by the Spanish Ministry (FPU18/05350). Work in the laboratory of IdP was funded by the MICINN (RTI2018-100872-J-I00) and PlaGenT excellence research program of the Valencian regional government (CIDENGENT/2019/044). Work in the laboratory of M.-I.G. was funded by PROMETEU/2018/135 from “Consellería, de Sanitat de la Generalitat Valenciana” and part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020). F.M. is grateful to the Austrian Science Fund FWF (SFB-LIPOTOX F3007 & F3012, W1226, P29203, P29262, P27893, and P31727); the Austrian Federal Ministry of Education, Science and Research and the University of Graz for grants Unkonventionelle Forschung-InterFast and ysleep (BMWFW-80.109/0001-WF/V/3b/2015) and the field of excellence program BioHealth. We acknowledge support from NAWI Graz, the BioTechMed-Graz agship project EPIAge. T.E. acknowledges support from Austrian Science Fund FWF (P 33957 and TAI 602 1000). Work in the laboratory of R.H.H. was financially supported by a VIDI grant from ZonMw (no. 91715305). J.S.D. was supported by Ohio University. D.F.-S. acknowledges Ministerio de Universidades in Spain for his Margarita Salas postdoctoral grant (Ref. MGS/2021/15). The CGC group is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).
Repisalud
Publication Artículo científico (JournalArticle)

Effects of long-term individual housing of middle-aged female Octodon degus on spatial learning and memory in the Barnes maze task

  • Popović, Natalija
  • Baño-Otalora, Beatriz
  • Rol, Maria-Angeles
  • Venero, César
  • Madrid, Juan Antonio
  • Popović, Miroljub
Introduction: Prolonged social isolation is a form of passive chronic stress that has consequences on human and animal behavior. The present study was undertaken to elucidate whether the long-term isolation would precipitate age-related changes in anxiety and spatial learning and memory in degus. Methods: We investigated the effects of long-term social isolation on anxiety levels in the light-dark test, and spatial orientation abilities in the Barnes maze. Middle-aged female Octodon degus were allocated to either group-housed (3 animals per cage) or individually-housed for 5 months. Results: Under this experimental condition, there were no significant group differences in the anxiety level tested in the light-dark test and in the motivation to escape from the Barnes maze. There were no significant differences in cortisol levels between individually- and group-housed animals. On the last acquisition training day of spatial learning, individually- housed animals had a significantly higher number of correct responses and a smaller number of reference and working memory errors than the group-housed animals. In addition, isolated animals showed a tendency for reference and working memory impairment on the retention trial, while group-housed degus showed improvement in these parameters. Discussion and conclusion: The present study indicates that prolonged social isolation during adulthood in female degus has a dual effect on spatial orientation. Specifically, it results in a significant improvement in acquisition skills but a slight impairment in memory retention. The obtained cognitive changes were not accompanied by modification in anxiety and cortisol levels.
Repisalud
Publication Artículo científico (JournalArticle)

Living at the Wrong Time: Effects of Unmatching Official Time in Portugal and Western Spain

  • Bonmatí-Carrión, María-Ángeles
  • Casado-Ramirez, Elvira
  • Moreno-Casbas, Teresa
  • Campos, Manuel
  • ModulEN Consortium
  • Madrid, Juan Antonio
  • Rol, Maria-Angeles
Human circadian rhythmicity is subjected to the internal circadian clock, the sun and social clocks (official time, social/work schedules). The discrepancy among these clocks, as occurs when official time does not match its geographical time zone, may produce circadian disruption. Western Spain (GMT+1/+2) and Portugal (GMT0/+1) share similar longitudes (sun time) but have different official times. This provides a unique opportunity to evaluate the effects of official time on circadian rhythmicity and sleep in elderly and retired populations (with no remunerated duties presumed, although other social commitments may be present) at both locations. Although both populations slept enough for their age (7-8 h), circadian robustness (e.g., interdaily stability, relative amplitude) was greater in Portugal, especially during weekdays, while greater desynchronization (both body temperature vs. motor activity and body temperature vs. light exposure) tended to occur in the Spaniards. Once corrected by GMT0, meals took place later in Spain than in Portugal, especially as the day progresses, and a possible interplay between bed/meal timings and internal desynchronization was found. Our results point to the possible deleterious effect on circadian system robustness when official time is misaligned with its geographical time zone.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Adult Neural Stem Cell Migration Is Impaired in a Mouse Model of Alzheimer&apos, s Disease

  • Esteve, Daniel
  • Molina-Navarro, María Micaela
  • Martínez-Varea, Noelia
  • Blanco-Gandia, Mari Carmen
  • Rodríguez-Arias, Marta
  • García-Verdugo, Jose Manuel
  • Viña, José
  • Lloret, Ana
  • Giraldo, Esther|||0000-0001-5488-3011
[EN] Neurogenesis in the adult brain takes place in two neurogenic niches: the ventricular-subventricular zone (V-SVZ) and the subgranular zone. After differentiation, neural precursor cells (neuroblasts) have to move to an adequate position, a process known as neuronal migration. Some studies show that in Alzheimer's disease, the adult neurogenesis is impaired. Our main aim was to investigate some proteins involved both in the physiopathology of Alzheimer's disease and in the neuronal migration process using the APP/PS1 Alzheimer's mouse model. Progenitor migrating cells are accumulated in the V-SVZ of the APP/PS1 mice. Furthermore, we find an increase of Cdh1 levels and a decrease of Cdk5/p35 and cyclin B1, indicating that these cells have an alteration of the cell cycle, which triggers a senescence state. We find less cells in the rostral migratory stream and less mature neurons in the olfactory bulbs from APP/PS1 mice, leading to an impaired odour discriminatory ability compared with WT mice. Alzheimer's disease mice present a deficit in cell migration from V-SVZ due to a senescent phenotype. Therefore, these results can contribute to a new approach of Alzheimer's based on senolytic compounds or pro-neurogenic factors., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by the following grants: Instituto de Salud Carlos III CB16/10/00435 (CIBER-FES), (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from `Conselleria, de Sanitat de la Generalitat Valenciana' and EU Funded H2020-DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative `A Healthy Diet for a Healthy Life' (JPI HDHL) and of the ERA-NET Cofound ERA-HDHL (GA No 696295 of the EU Horizon 2020 Research and Innovation Programme). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). Special Research Actions from University of Valencia (REF: UV-INV-AE-1546096).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer s Disease

  • Monllor, Paloma
  • Badia, Mari-Carmen
  • García de la Asunción, José
  • Alonso, Maria-Dolores
  • Lloret, Ana
  • Viña, Jose
  • Giraldo, Esther|||0000-0001-5488-3011
[EN] Background: Alzheimer's disease (AD) is the most common form of dementia and biomarkers are essential to help in the diagnosis of this disease. Image techniques and cerebrospinal fluid (CSF) biomarkers are limited in their use because they are expensive or invasive. Thus, the search for blood-borne biomarkers is becoming central to the medical community. Objective: The main objective of this study is the evaluation of three serum proteins as potential biomarkers in AD patients. Methods: We recruited 27 healthy controls, 19 mild cognitive impairment patients, and 17 AD patients. Using the recent A/T/N classification we split our population into two groups (AD and control). We used ELISA kits to determine Aß42, tau, and p-tau in CSF and clusterin, PKR, and RAGE in serum. Results: The levels of serum clusterin, PKR, and RAGE were statistically different in the AD group compared to controls. These proteins showed a statistically significant correlation with CSF Aß42. So, they were selected to generate an AD detection model showing an AUC-ROC of 0.971 (CI 95%, 0.931-0.998). Conclusion: The developed model based on serum biomarkers and other co-variates could reflect the AD core pathology. So far, not one single blood-biomarker has been described, with effectiveness offering high sensitivity and specificity. We propose that the complexity of AD pathology could be reflected in a set of biomarkers also including clinical features of the patients., This work was supported by the following grants: Instituto de Salud Carlos III CB16/10/00435 (CIBE RFES), (PID2019-110906RB-I00/AEI/10.13039/50 1100011033) from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 de "Conselleria, de Sanitat de la Generalitat Valenciana" and EU Funded H2020-DIABFRAIL-LATAM(Ref: 825546), European Joint Programming Initiative "A Healthy Diet for a Healthy Life" (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N. 696295 of the EU Horizon 2020 Research and Innovation Programme). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). We also thank Mrs Marilyn Noyes for her kind help in reviewing the manuscript. The authors thank Francisco Santonja for the statistical analysis support.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Phenotypic upregulation of hexocylceramides and ether-linked phosphocholines as markers of human extreme longevity

  • Fernández Bernal, Anna
  • Sol, Joaquim
  • Galo-Licona, José Daniel
  • Mota Martorell, Natàlia
  • Mas-Bargues, Cristina
  • Belenguer-Varea, Ángel
  • Obis Monné, Èlia
  • Viña Ribes, José
  • Borrás, Consuelo
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Centenarians and their relatives possess a notable survival advantage, with higher longevity and reduced susceptibility to major age-related diseases. To date, characteristic omics profiles of centenarians have been described, demonstrating that these individuals with exceptional longevity regulate their metabolism to adapt and incorporate more resilient biomolecules into their cells. Among these adaptations, the lipidomic profile stands out. However, it has not yet been determined whether this lipidomic profile is specific to centenarians or is the consequence of extreme longevity genetics and is also present in centenarians' offspring. This distinction is crucial for defining potential therapeutic targets that could help delay the aging process and associated pathologies. We applied mass-spectrometry-based techniques to quantify 569 lipid species in plasma samples from 39 centenarians, 63 centenarians' offspring, and 69 noncentenarians' offspring without familial connections. Based on this profile, we calculated different indexes to characterize the functional and structural properties of plasma lipidome. Our findings demonstrate that extreme longevity genetics (centenarians and centenarians' offspring) determines a specific lipidomic signature characterized by (i) an enrichment of hexosylceramides, (ii) a decrease of specific species of ceramides and sulfatides, (iii) a global increase of ether-PC and ether-LPC, and (iv) changes in the fluidity and diversity of specific lipid classes. We point out the conversion of ceramides to hexosylceramides and the maintenance of the levels of the ether-linked PC as a phenotypic trait to guarantee extreme longevity. We propose that this molecular signature is the result of an intrinsic adaptive program that preserves protective mechanisms and cellular identity., Ministerio de Ciencia y Tecnología, Grant/Award Number: PID2020-113839RB-I00 and PID2023-152233OB-I00; Diputació de Lleida, Grant/Award Number:PP10605-PIRS2021 and PP10845-PIRS2023; Instituto de Salud Carlos III,Grant/Award Number: AC20/00026,CB16/10/00435 (CIBERFES) and PI24/01431; Conselleria d'Educació,Investigació, Cultura i Esport, Grant/Award Number: CIAICO/2022/190; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Grant/Award Number: 2021SGR00990; Horizon 2020 Framework Programme, Grant/Award Number: 696295 and 825546
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus

  • Borrás, Consuelo
  • Abdelaziz, Kheira M.
  • Díaz, Ana
  • Gambini,Juan
  • Jové Font, Mariona
  • López-Grueso, Raul
  • Mas-Bargues, Cristina
  • Monleón, Daniel
  • Pamplona Gras, Reinald
  • Viña Ribes, José
Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diabetic Goto Kakizaki (GK) rats. Indeed, this was the case: we found that male GK rats consuming a soya-rich diet developed the disease at a lower rate and, therefore, lived longer than soya-free dietconsuming rats., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RBI00/AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería, de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N◦ 696295 of the EU Horizon 2020 Research and Innovation Programme) to J.V. and PID2020-113839RB-I00 of the Ministry of Science and Innovation, PCIN-2017-117 of the Ministry of Economy and Competitiveness, the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to C.B. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020)
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Glucose 6-P dehydrogenase delays the onset of frailty by protecting against muscle damage

  • Arc-Chagnaud, Coralie
  • Salvador Pascual, Andrea
  • Garcia Dominguez, Esther
  • Olaso Gonzalez, Gloria
  • Correas, Ángela G.
  • Serna, Eva
  • Brioche, Thomas
  • Chopard, Angele
  • Fernández Marcos, Pablo J.
  • Serrano Marugán, Manuel
  • Serrano, Antonio L.
  • Muñoz Cánoves, Pura, 1962-
  • Sebastia, Vicente
  • Viña, Jose
  • Gomez Cabrera, Mari Carmen
Background Frailty is a major age-associated syndrome leading to disability. Oxidative damage plays a significant role in the promotion of frailty. The cellular antioxidant system relies on reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is highly dependent on glucose 6-P dehydrogenase (G6PD). The G6PD-overexpressing mouse (G6PD-Tg) is protected against metabolic stresses. Our aim was to examine whether this protection delays frailty. Methods Old wild-type (WT) and G6PD-Tg mice were evaluated longitudinally in terms of frailty. Indirect calorimetry, transcriptomic profile, and different skeletal muscle quality markers and muscle regenerative capacity were also investigated. Results The percentage of frail mice was significantly lower in the G6PD-Tg than in the WT genotype, especially in 26-month-old mice where 50% of the WT were frail vs. only 13% of the Tg ones (P < 0.001). Skeletal muscle transcriptomic analysis showed an up-regulation of respiratory chain and oxidative phosphorylation (P = 0.009) as well as glutathione metabolism (P = 0.035) pathways in the G6PD-Tg mice. Accordingly, the Tg animals exhibited an increase in reduced glutathione (34.5%, P < 0.01) and a decrease on its oxidized form (-69%, P < 0.05) and in lipid peroxidation (4-HNE: -20.5%, P < 0.05). The G6PD-Tg mice also showed reduced apoptosis (BAX/Bcl2: -25.5%, P < 0.05; and Bcl-xL: -20.5%, P < 0.05), lower levels of the intramuscular adipocyte marker FABP4 (-54.7%, P < 0.05), and increased markers of mitochondrial content (COX IV: 89.7%, P < 0.05; Grp75: 37.8%, P < 0.05) and mitochondrial OXPHOS complexes (CII: 81.25%, P < 0.01; CIII: 52.5%, P < 0.01; and CV: 37.2%, P < 0.05). Energy expenditure (-4.29%, P < 0.001) and the respiratory exchange ratio were lower (-13.4%, P < 0.0001) while the locomotor activity was higher (43.4%, P < 0.0001) in the 20-month-old Tg, indicating a major energetic advantage in these mice. Short-term exercise training in young C57BL76J mice induced a robust activation of G6PD in skeletal muscle (203.4%, P < 0.05), similar to that achieved in the G6PD-Tg mice (142.3%, P < 0.01). Conclusions Glucose 6-P dehydrogenase deficiency can be an underestimated risk factor for several human pathologies and even frailty. By overexpressing G6PD, we provide the first molecular model of robustness. Because G6PD is regulated by pharmacological and physiological interventions like exercise, our results provide molecular bases for interventions that by increasing G6PD will delay the onset of frailty.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models

  • Costa-Machado, Luis Filipe
  • García-Domínguez, Esther
  • McIntyre, Rebecca L.
  • López-Aceituno, José Luis
  • Ballesteros-González, Álvaro
  • Tapia-González, Andrea
  • Fabregat-Safont, David
  • Eisenberg, Tobias
  • Gómez, Jesús
  • Plaza, Adrian
  • Sierra-Ramírez, Aranzazu
  • Pérez, Manuel
  • Villanueva-Bermejo, David
  • Fornari, Tiziana
  • Loza, María Isabel
  • Herradón, Gonzalo
  • Hofer, Sebastian J.
  • Magnes, Christoph
  • Madeo, Frank
  • Duerr, Janet S.
  • Pozo, Oscar J.
  • Galindo, Maximo-Ibo
  • Pino, Isabel del
  • Houtkooper, Riekelt H.
  • Megías, Diego
  • Viña, José
  • Gómez-Cabrera, Mari Carmen
  • Fernández-Marcos, Pablo José
Reversible and sub-lethal stresses to the mitochondria elicit a program of compensatory responses that ultimately improve mitochondrial function, a conserved anti-aging mechanism termed mitohormesis. Here, we show that harmol, a member of the beta-carbolines family with anti-depressant properties, improves mitochondrial function and metabolic parameters, and extends healthspan. Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain barrier. Mechanistically, simultaneous modulation of the targets of harmol monoamine-oxidase B and GABA-A receptor reproduces harmol-induced mitochondrial improvements. Diet-induced pre-diabetic male mice improve their glucose tolerance, liver steatosis and insulin sensitivity after treatment with harmol. Harmol or a combination of monoamine oxidase B and GABA-A receptor modulators extend the lifespan of hermaphrodite Caenorhabditis elegans or female Drosophila melanogaster. Finally, two-year-old male and female mice treated with harmol exhibit delayed frailty onset with improved glycemia, exercise performance and strength. Our results reveal that peripheral targeting of monoamine oxidase B and GABA-A receptor, common antidepressant targets, extends healthspan through mitohormesis., L.F.C.-M. was supported by the IMDEA Food institute and by a PhD Fellowship from the Portuguese Foundation for Science and Technology (FCT‐MCTES, SFRH/BD/124022/2016). Work in the laboratory of P.J.F.-M. was funded by the IMDEA Food Institute, the Ramón Areces Foundation (CIVP18A3891), the AECC (SIRTBIO, LABAE18008FERN), the MICINN (SAF2017-85766-R and PRPPID2020-114077RB-I00) co-funded by the European Regional Development Fund, and a Ramon y Cajal Fellowship (MICINN, RYC-2017-22335). J.L.L.-A. was funded by the Spanish Ministry of Science and Innovation (MICINN) (PTA2017‐14689‐I). Work in FreshAge laboratory was funded by: Instituto de Salud Carlos III CB16/10/00435 (CIBERFES), (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish Ministry of Innovation and Science; FGCSIC/PSLINTERREG/FEDER; PROMETEO/2019/097 de “Consellería de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana). Support from Ramón Areces Fundation and Soria Melguizo Foundation is also acknowledged. E.G.-D. was a recipient of a predoctoral grant financed by the Spanish Ministry (FPU18/05350). Work in the laboratory of IdP was funded by the MICINN (RTI2018-100872-J-I00) and PlaGenT excellence research program of the Valencian regional government (CIDENGENT/2019/044). Work in the laboratory of M.-I.G. was funded by PROMETEU/2018/135 from “Consellería, de Sanitat de la Generalitat Valenciana” and part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020). F.M. is grateful to the Austrian Science Fund FWF (SFB-LIPOTOX F3007 & F3012, W1226, P29203, P29262, P27893, and P31727); the Austrian Federal Ministry of Education, Science and Research and the University of Graz for grants Unkonventionelle Forschung-InterFast and ysleep (BMWFW-80.109/0001-WF/V/3b/2015) and the field of excellence program BioHealth. We acknowledge support from NAWI Graz, the BioTechMed-Graz agship project EPIAge. T.E. acknowledges support from Austrian Science Fund FWF (P 33957 and TAI 602 1000). Work in the laboratory of R.H.H. was financially supported by a VIDI grant from ZonMw (no. 91715305). J.S.D. was supported by Ohio University. D.F.-S. acknowledges Ministerio de Universidades in Spain for his Margarita Salas postdoctoral grant (Ref. MGS/2021/15). The CGC group is funded by NIH Office of Research Infrastructure Programs (P40 OD010440)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Changes in health behaviors, mental and physical health among older adults under severe lockdown restrictions during the covid-19 pandemic in spain

  • García-Esquinas E.
  • Ortolá R.
  • Gine-Vázquez I.
  • Carnicero J.A.
  • Mañas A.
  • Lara E.
  • Alvarez-Bustos A.
  • Vicente-Rodriguez G.
  • Sotos-Prieto M.
  • Olaya B.
  • Garcia-Garcia F.J.
  • Gusi N.
  • Banegas J.R.
  • Rodríguez-Gómez I.
  • Struijk E.A.
  • Martínez-Gómez D.
  • Lana A.
  • Haro J.M.
  • Ayuso-Mateos J.L.
  • Rodríguez-Mañas L.
  • Ara I.
  • Miret M.
  • Rodríguez-Artalejo F.
We used data from 3041 participants in four cohorts of community-dwelling individuals aged =65 years in Spain collected through a pre-pandemic face-to-face interview and a telephone interview conducted between weeks 7 to 15 after the beginning of the COVID-19 lockdown. On average, the confinement was not associated with a deterioration in lifestyle risk factors (smoking, alcohol intake, diet, or weight), except for a decreased physical activity and increased sedentary time, which reversed with the end of confinement. However, chronic pain worsened, and moderate declines in mental health, that did not seem to reverse after restrictions were lifted, were observed. Males, older adults with greater social isolation or greater feelings of loneliness, those with poorer housing conditions, as well as those with a higher prevalence of chronic morbidities were at increased risk of developing unhealthier lifestyles or mental health declines with confinement. On the other hand, previously having a greater adherence to the Mediterranean diet and doing more physical activity protected older adults from developing unhealthier lifestyles with confinement. If an-other lockdown were imposed during this or future pandemics, public health programs should spe-cially address the needs of older individuals with male sex, greater social isolation, sub-optimal housing conditions, and chronic morbidities because of their greater vulnerability to the enacted movement restrictions. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP/PS1 mouse model of Alzheimer’s disease

  • Correas, Ángela G.
  • Olaso-Gonzalez, Gloria
  • Roca, Marta
  • Blanco-Gandía, Mari Carmen
  • Nascimento, Carla
  • Lahoz, Agustín
  • Rodríguez-Arias, Marta
  • Miñarro, José
  • Gómez-Cabrera, Mari Carmen
  • Viña, José
Mice models of Alzheimer's disease (APP/PS1) typically experience cognitive decline with age. G6PD overexpressing mice (G6PD-Tg) exhibit better protection from age-associated functional decline including improvements in metabolic and muscle functions as well as reduced frailty compared to their wild-type counterparts. Importantly G6PD-Tg mice show diminished accumulation of DNA oxidation in the brain at different ages in both males and females. To further explore the potential benefits of modulating the G6PD activity in neurodegenerative diseases, triple transgenic mice (3xTg G6PD) were generated, overexpressing APP, PSEN1, and G6PD genes. The cognitive decline characteristic of APP/PS1 mice was prevented in 3xTg G6PD mice, despite similar amyloid-β (Aβ) levels in the hippocampus. This challenges the dominant hypothesis in Alzheimer's disease (AD) etiology and the majority of therapeutic efforts in the field, based on the notion that Aβ is pivotal in cognitive preservation. Notably, the antioxidant properties of G6PD led to a decrease in oxidative stress parameters, such as improved GSH/GSSG and GSH/CysSSG ratios, without major changes in oxidative damage markers. Additionally, metabolic changes in 3xTg G6PD mice increased brain energy status, countering the hypometabolism observed in Alzheimer's models. Remarkably, a higher respiratory exchange ratio suggested increased carbohydrate utilization. The relative failures of Aβ-targeted clinical trials have raised significant skepticism on the amyloid cascade hypothesis and whether the development of Alzheimer's drugs has followed the correct path. Our findings highlight the significance of targeting glucose-metabolizing enzymes rather than solely focusing on Aβ in Alzheimer's research, advocating for a deeper exploration of glucose metabolism's role in cognitive preservation.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models

  • Costa-Machado, Luis Filipe
  • Fabregat-Safont, David
  • Pozo Mendoza, Óscar J., 1975-
  • Fernandez-Marcos, Pablo J.
Reversible and sub-lethal stresses to the mitochondria elicit a program of compensatory responses that ultimately improve mitochondrial function, a conserved anti-aging mechanism termed mitohormesis. Here, we show that harmol, a member of the beta-carbolines family with anti-depressant properties, improves mitochondrial function and metabolic parameters, and extends healthspan. Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain barrier. Mechanistically, simultaneous modulation of the targets of harmol monoamine-oxidase B and GABA-A receptor reproduces harmol-induced mitochondrial improvements. Diet-induced pre-diabetic male mice improve their glucose tolerance, liver steatosis and insulin sensitivity after treatment with harmol. Harmol or a combination of monoamine oxidase B and GABA-A receptor modulators extend the lifespan of hermaphrodite Caenorhabditis elegans or female Drosophila melanogaster. Finally, two-year-old male and female mice treated with harmol exhibit delayed frailty onset with improved glycemia, exercise performance and strength. Our results reveal that peripheral targeting of monoamine oxidase B and GABA-A receptor, common antidepressant targets, extends healthspan through mitohormesis., Work in the laboratory of P.J.F.-M. was funded by the IMDEA Food Institute, the Ramón Areces Foundation (CIVP18A3891), the AECC (SIRTBIO, LABAE18008FERN), the MICINN (SAF2017-85766-R and PRPPID2020-114077RB-I00) co-funded by the European Regional Development Fund, and a Ramon y Cajal Fellowship (MICINN, RYC-2017-22335). J.L.L.-A. was funded by the Spanish Ministry of Science and Innovation (MICINN) (PTA2017‐14689‐I). Work in FreshAge laboratory was funded by: Instituto de Salud Carlos III CB16/10/00435 (CIBERFES), (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish Ministry of Innovation and Science; FGCSIC/PSLINTERREG/FEDER; PROMETEO/2019/097 de “Consellería de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana). Support from Ramón Areces Fundation and Soria Melguizo Foundation is also acknowledged. E.G.-D. was a recipient of a predoctoral grant financed by the Spanish Ministry (FPU18/05350). Work in the laboratory of IdP was funded by the MICINN (RTI2018-100872-J-I00) and PlaGenT excellence research program of the Valencian regional government (CIDENGENT/2019/044). Work in the laboratory of M.-I.G. was funded by PROMETEU/2018/135 from “Consellería, de Sanitat de la Generalitat Valenciana” and part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020). F.M. is grateful to the Austrian Science Fund FWF (SFB-LIPOTOX F3007 & F3012, W1226, P29203, P29262, P27893, and P31727); the Austrian Federal Ministry of Education, Science and Research and the University of Graz for grants Unkonventionelle Forschung-InterFast and ysleep (BMWFW-80.109/0001-WF/V/3b/2015) and the field of excellence program BioHealth. We acknowledge support from NAWI Graz, the BioTechMed-Graz agship project EPIAge. T.E. acknowledges support from Austrian Science Fund FWF (P 33957 and TAI 602 1000). Work in the laboratory of R.H.H. was financially supported by a VIDI grant from ZonMw (no. 91715305). J.S.D. was supported by Ohio University. D.F.-S. acknowledges Ministerio de Universidades in Spain for his Margarita Salas postdoctoral grant (Ref. MGS/2021/15). The CGC group is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus

  • Borrás, Consuelo
  • Abdelaziz, Kheira M.
  • Díaz, Ana
  • Gambini,Juan
  • Jové Font, Mariona
  • López-Grueso, Raul
  • Mas-Bargues, Cristina
  • Monleón, Daniel
  • Pamplona Gras, Reinald
  • Viña Ribes, José
Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diabetic Goto Kakizaki (GK) rats. Indeed, this was the case: we found that male GK rats consuming a soya-rich diet developed the disease at a lower rate and, therefore, lived longer than soya-free dietconsuming rats., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RBI00/AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería, de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N◦ 696295 of the EU Horizon 2020 Research and Innovation Programme) to J.V. and PID2020-113839RB-I00 of the Ministry of Science and Innovation, PCIN-2017-117 of the Ministry of Economy and Competitiveness, the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to C.B. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Glucose 6-P dehydrogenase delays the onset of frailty by protecting against muscle damage

  • Arc-Chagnaud, Coralie
  • Salvador-Pascual, Andrea
  • Garcia-Dominguez, Esther
  • Olaso-Gonzalez, Gloria
  • Correas, Angela G.
  • Serna, Eva
  • Brioche, Thomas
  • Chopard, Angele
  • Fernandez-Marcos, Pablo J.
  • Serrano, Manuel
  • Serrano, Antonio L.
  • Muñoz Cánoves, Pura, 1962-
  • Sebastiá, Vicente
  • Viña, Jose
  • Gomez-Cabrera, Mari Carmen
Background: Frailty is a major age-associated syndrome leading to disability. Oxidative damage plays a significant role in the promotion of frailty. The cellular antioxidant system relies on reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is highly dependent on glucose 6-P dehydrogenase (G6PD). The G6PD-overexpressing mouse (G6PD-Tg) is protected against metabolic stresses. Our aim was to examine whether this protection delays frailty. Methods: Old wild-type (WT) and G6PD-Tg mice were evaluated longitudinally in terms of frailty. Indirect calorimetry, transcriptomic profile, and different skeletal muscle quality markers and muscle regenerative capacity were also investigated. Results: The percentage of frail mice was significantly lower in the G6PD-Tg than in the WT genotype, especially in 26-month-old mice where 50% of the WT were frail vs. only 13% of the Tg ones (P < 0.001). Skeletal muscle transcriptomic analysis showed an up-regulation of respiratory chain and oxidative phosphorylation (P = 0.009) as well as glutathione metabolism (P = 0.035) pathways in the G6PD-Tg mice. Accordingly, the Tg animals exhibited an increase in reduced glutathione (34.5%, P < 0.01) and a decrease on its oxidized form (-69%, P < 0.05) and in lipid peroxidation (4-HNE: -20.5%, P < 0.05). The G6PD-Tg mice also showed reduced apoptosis (BAX/Bcl2: -25.5%, P < 0.05; and Bcl-xL: -20.5%, P < 0.05), lower levels of the intramuscular adipocyte marker FABP4 (-54.7%, P < 0.05), and increased markers of mitochondrial content (COX IV: 89.7%, P < 0.05; Grp75: 37.8%, P < 0.05) and mitochondrial OXPHOS complexes (CII: 81.25%, P < 0.01; CIII: 52.5%, P < 0.01; and CV: 37.2%, P < 0.05). Energy expenditure (-4.29%, P < 0.001) and the respiratory exchange ratio were lower (-13.4%, P < 0.0001) while the locomotor activity was higher (43.4%, P < 0.0001) in the 20-month-old Tg, indicating a major energetic advantage in these mice. Short-term exercise training in young C57BL76J mice induced a robust activation of G6PD in skeletal muscle (203.4%, P < 0.05), similar to that achieved in the G6PD-Tg mice (142.3%, P < 0.01). Conclusions: Glucose 6-P dehydrogenase deficiency can be an underestimated risk factor for several human pathologies and even frailty. By overexpressing G6PD, we provide the first molecular model of robustness. Because G6PD is regulated by pharmacological and physiological interventions like exercise, our results provide molecular bases for interventions that by increasing G6PD will delay the onset of frailty., This work was supported by Instituto de Salud Carlos III CB16/10/00435 (CIBERFES) (PID2019-110906RB-I00/AEI/10.13039/501100011033) from the Spanish Ministry of Innovation and Science; 109_RESIFIT from Fundación General CSIC; PROMETEO/2019/097 de ‘Consellería, de Sanitat de la Generalitat Valenciana’ and EU Funded H2020-DIABFRAIL-LATAM (Ref: 825546); European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL); and the ERA-NET Cofund ERA-HDHL (GA No. 696295 of the EU Horizon 2020 Research and Innovation Programme). Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020). Work in the laboratory of P.J.F.-M. was funded by the FBBVA and the Ramón Areces Foundations. Work in the laboratory of P.M.-C. and A.L.S was funded by by MWRF and Fundació La Marató/TV3-80/19-202021 to P.M.C. and Fundació La Marató de TV3 (Project 202033 to A.L.S.), MINECO-Spain (RTI2018-096068), ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, and DPP-Spain; María-de-Maeztu-Program for Units of Excellence to UPF (MDM-2014-0370); and Severo-Ochoa-Program for Centers of Excellence to CNIC (SEV-2015-0505). A.S.-P. was supported by a fellowship from the Spanish ‘Ministerio de Educación, Cultura y Deporte’, award FPU 14/00098.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Glucose 6-P dehydrogenase delays the onset of frailty by protecting against muscle damage

  • Arc-Chagnaud, Coralie
  • Salvador Pascual, Andrea
  • Garcia Dominguez, Esther
  • Olaso Gonzalez, Gloria
  • Correas, Ángela G.
  • Serna, Eva
  • Brioche, Thomas
  • Chopard, Angele
  • Fernández Marcos, Pablo J.
  • Serrano Marugán, Manuel
  • Serrano, Antonio L.
  • Muñoz Cánoves, Pura, 1962-
  • Sebastia, Vicente
  • Viña, Jose
  • Gomez Cabrera, Mari Carmen
Background Frailty is a major age-associated syndrome leading to disability. Oxidative damage plays a significant role in the promotion of frailty. The cellular antioxidant system relies on reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is highly dependent on glucose 6-P dehydrogenase (G6PD). The G6PD-overexpressing mouse (G6PD-Tg) is protected against metabolic stresses. Our aim was to examine whether this protection delays frailty. Methods Old wild-type (WT) and G6PD-Tg mice were evaluated longitudinally in terms of frailty. Indirect calorimetry, transcriptomic profile, and different skeletal muscle quality markers and muscle regenerative capacity were also investigated. Results The percentage of frail mice was significantly lower in the G6PD-Tg than in the WT genotype, especially in 26-month-old mice where 50% of the WT were frail vs. only 13% of the Tg ones (P < 0.001). Skeletal muscle transcriptomic analysis showed an up-regulation of respiratory chain and oxidative phosphorylation (P = 0.009) as well as glutathione metabolism (P = 0.035) pathways in the G6PD-Tg mice. Accordingly, the Tg animals exhibited an increase in reduced glutathione (34.5%, P < 0.01) and a decrease on its oxidized form (-69%, P < 0.05) and in lipid peroxidation (4-HNE: -20.5%, P < 0.05). The G6PD-Tg mice also showed reduced apoptosis (BAX/Bcl2: -25.5%, P < 0.05; and Bcl-xL: -20.5%, P < 0.05), lower levels of the intramuscular adipocyte marker FABP4 (-54.7%, P < 0.05), and increased markers of mitochondrial content (COX IV: 89.7%, P < 0.05; Grp75: 37.8%, P < 0.05) and mitochondrial OXPHOS complexes (CII: 81.25%, P < 0.01; CIII: 52.5%, P < 0.01; and CV: 37.2%, P < 0.05). Energy expenditure (-4.29%, P < 0.001) and the respiratory exchange ratio were lower (-13.4%, P < 0.0001) while the locomotor activity was higher (43.4%, P < 0.0001) in the 20-month-old Tg, indicating a major energetic advantage in these mice. Short-term exercise training in young C57BL76J mice induced a robust activation of G6PD in skeletal muscle (203.4%, P < 0.05), similar to that achieved in the G6PD-Tg mice (142.3%, P < 0.01). Conclusions Glucose 6-P dehydrogenase deficiency can be an underestimated risk factor for several human pathologies and even frailty. By overexpressing G6PD, we provide the first molecular model of robustness. Because G6PD is regulated by pharmacological and physiological interventions like exercise, our results provide molecular bases for interventions that by increasing G6PD will delay the onset of frailty.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Phenotypic upregulation of hexocylceramides and ether-linked phosphocholines as markers of human extreme longevity

  • Fernández Bernal, Anna
  • Sol, Joaquim
  • Galo-Licona, José Daniel
  • Mota Martorell, Natàlia
  • Mas-Bargues, Cristina
  • Belenguer-Varea, Ángel
  • Obis Monné, Èlia
  • Viña Ribes, José
  • Borrás, Consuelo
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Centenarians and their relatives possess a notable survival advantage, with higher longevity and reduced susceptibility to major age-related diseases. To date, characteristic omics profiles of centenarians have been described, demonstrating that these individuals with exceptional longevity regulate their metabolism to adapt and incorporate more resilient biomolecules into their cells. Among these adaptations, the lipidomic profile stands out. However, it has not yet been determined whether this lipidomic profile is specific to centenarians or is the consequence of extreme longevity genetics and is also present in centenarians' offspring. This distinction is crucial for defining potential therapeutic targets that could help delay the aging process and associated pathologies. We applied mass-spectrometry-based techniques to quantify 569 lipid species in plasma samples from 39 centenarians, 63 centenarians' offspring, and 69 noncentenarians' offspring without familial connections. Based on this profile, we calculated different indexes to characterize the functional and structural properties of plasma lipidome. Our findings demonstrate that extreme longevity genetics (centenarians and centenarians' offspring) determines a specific lipidomic signature characterized by (i) an enrichment of hexosylceramides, (ii) a decrease of specific species of ceramides and sulfatides, (iii) a global increase of ether-PC and ether-LPC, and (iv) changes in the fluidity and diversity of specific lipid classes. We point out the conversion of ceramides to hexosylceramides and the maintenance of the levels of the ether-linked PC as a phenotypic trait to guarantee extreme longevity. We propose that this molecular signature is the result of an intrinsic adaptive program that preserves protective mechanisms and cellular identity., Ministerio de Ciencia y Tecnología, Grant/Award Number: PID2020-113839RB-I00 and PID2023-152233OB-I00; Diputació de Lleida, Grant/Award Number:PP10605-PIRS2021 and PP10845-PIRS2023; Instituto de Salud Carlos III,Grant/Award Number: AC20/00026,CB16/10/00435 (CIBERFES) and PI24/01431; Conselleria d'Educació,Investigació, Cultura i Esport, Grant/Award Number: CIAICO/2022/190; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Grant/Award Number: 2021SGR00990; Horizon 2020 Framework Programme, Grant/Award Number: 696295 and 825546
RUO. Repositorio Institucional de la Universidad de Oviedo
Publication Artículo científico (JournalArticle)

Changes in health behaviors, mental and physical health among older adults under severe lockdown restrictions during the COVID-19 pandemic in Spain

  • García Esquinas, Esther
  • Ortola, Rosario
  • Gine Vázquez, Iago
  • Carnicero, José A.
  • Lana Pérez, Alberto|||0000-0003-0500-8805
The Seniors-ENRICA-2 study was supported by Instituto de Salud Carlos III (Spain), State Secretary of R+D+I and FEDER/FSE research grants PI16/609, PI18/287, and 19/319; ELS was supported by a Juan de la Cierva Contract from the Ministy of Universities. DMG and MSP were supported by supported by a “Ramón y Cajal” contract. "Edad con Salud" was funded by the Seventh Framework Programme (grant number 223071-COURAGE Study); the Instituto de Salud Carlos III (grants number PS09/00295(JMH), PS09/01845 (JLA), PI12/01490 (JMH), PI13/00059 (JLA), PI16/00212 (JMH), PI16/00218 (MM), PI16/01073 (JLA)); the European Regional Development Fund (ERDF) “A Way to Build Europe” (grant numbers PI12/01490, PI13/00059, PI16/00212 and PI16/01073). The Toledo Study for Healthy Ageing was funded by the Spanish Ministry of Economy, Industry and Competitiveness, cofinanced by FEDER (RD120001/0043),CIBERFES (CB16/10/00464) and DIABFRAIL-LATAM (contract number 825546, Horizon 2020) (...), García-Esquinas, E., Ortolá, R., Gine-Vázquez, I., Carnicero, J.A., Mañas, A., Lara, E., Alvarez-Bustos, A., Vicente-Rodriguez, G., Sotos-Prieto, M., Olaya, B., Garcia-Garcia, F.J., Gusi, N., Banegas, J.R., Rodríguez-Gómez, I., Struijk, E.A., Martínez-Gómez, D., Lana, A., Haro, J.M., Ayuso-Mateos, J.L., Rodríguez-Mañas, L., Ara, I., Miret, M., Rodríguez-Artalejo, F.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Intrinsic capacity as a predictor of depression onset in middle-aged and older adults: insights from the UK Biobank

  • Ramírez Vélez, Robinson
  • Borda, Miguel Germán
  • López Sáez de Asteasu, Mikel
  • Izquierdo Redín, Mikel
Background: Intrinsic capacity (IC), defined as an individual’s overall physical and mental capabilities, is central to healthy aging. It is, however, less clear to what degree there is an association between IC and the onset of depressive symptoms. Methods: We analyzed the data of 426,714 participants enrolled in the UK Biobank. The variation in sample size (range: 398,775–414,232) reflects differences across specific domain-level data completeness. Seven biomarkers reflecting functional ability across the five IC domains were used to compute a composite IC score ranging from 0 (optimal IC) to +4 (most impaired IC). The associations between IC scores and incident depressive disorders were also assessed. Results: After a median follow-up of 10.6 years (cutoff date: December 31, 2022), 42,537 new cases of psychiatric disorders were recorded, of which 13,464 (31 %) were attributed primarily to depression. A progressive increase in the prevalence of individual IC impairments was observed along with the rising incidence of depression. In multivariable models, higher IC scores were significantly associated with an increased risk of depression: hazard ratio (HR) [95 % confidence interval (CI)] of 3.91 (3.44–4.45) in men (C-index = 0.66) and 3.94 (3.57–4.35) in women (C-index = 0.66). These associations were confirmed using sensitivity analysis. As this was an observational study, reverse causality cannot be ruled out. Conclusions: Higher IC impairment scores are associated with an elevated risk of developing depressive disorders. While causality cannot be inferred, the measure of IC may be used to identify individuals who are at higher risk, and to guide early, targeted preventive strategies., Open access funding provided by Universidad P\u00FAblica de Navarra. This study was funded in part by la Uni\u00F3n Europe and Ministerio de Ciencia e Innovaci\u00F3n, Agencia Estatal de Investigaci\u00F3n (AEI), Uni\u00F3n Europea NextGeneration EU/PRTR with number PLEC2021-0080171 and EU Funded H2020-DIABFRAIL-LATAM (Ref: 825546).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Editorial: Evidence-based exercise enhances healthy aging

  • Izquierdo Redín, Mikel
  • Fiatarone Singh, Maria
As the global population continues to age, an urgent question arises: how can we improve the quality of life for older adults while reducing the burden of age-related diseases and disabilities? A growing body of evidence suggests that evidence-based exercise, used as both preventive and therapeutic medicine, may hold the key to extending healthy As the global population continues to age, an urgent question arises: howcanweimprovethequalityoflifeforolderadultswhilereducingthe burden of age-related diseases and disabilities? A growing body of evidence suggests that evidence-based exercise, used as both preventive and therapeutic medicine, may hold the key to extending healthy longevity, preventing chronic conditions, and preserving physical and cognitive function. The “Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR)” emphasizes the importance of integrating tailored exercise regimens into geriatric care, positioning exercise not only as preventive medicine but also as a therapeutic cornerstone in managing age-related decline. The updated consensus document introduces several advancements that distinguish it from the previous consensus published a few years ago. It emphasizes more personalized, evidence-based exercise prescriptions that align with individual health profiles and conditions, moving beyond genericactivityguidelines., Prof. Mikel Izquierdo was supported in part by «Proyectos de I+D+i» de los Programas Estatales de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i Orientada a los Retos de la Sociedad, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (PID2020-113098RBI00) and by the European Union and Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (AEI), Unión Europea NextGenerationEU/PRTR with number PLEC2021-0080171 and by EU Funded H2020-DIABFRAIL-LATAM (H2020-SC1-BHC-825546).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Effects of physical exercise on metabolic syndrome in psychotic disorders: a systematic review with meta-analysis of randomized controlled trials

  • Ancín Osés, Arantxa
  • Izquierdo Redín, Mikel
  • Cuesta, Manuel J.
  • López Sáez de Asteasu, Mikel
Background. Physical exercise improves mental and physical health of individuals with severe mental illness (SMI); however, its impact on metabolic syndrome remains unclear. Aims. To evaluate the effects of exercise interventions on metabolic syndrome components in individuals with SMI and explore interactions between exercise and antipsychotic medications on metabolic outcomes. Methods. Following PRISMA guidelines, we systematically searched PubMed, CINAHL, Web of Science, and APA PsycINFO through October 10, 2023, for randomized controlled trials (RCTs) assessing the effects of exercise on waist circumference, blood pressure, glucose, triglycerides, and HDL cholesterol in SMI. Risk of bias was evaluated using the Cochrane RoB-2 tool. Data were pooled using random-effects models in Comprehensive Meta-Analysis and JASP. Results. Ten RCTs (N = 773; mean age 39.9 ± 7.36 years; 38.7% female; 71.5% schizophrenia spectrum disorders) met inclusion criteria. Pooled analyses revealed no significant effects of exercise on waist circumference (SMD = 0.206, 95% CI [-0.118, 0.530], p = 0.171), systolic blood pressure (SMD = 0.194, 95% CI [-0.115, 0.504], p = 0.219), diastolic blood pressure (SMD = -0.21, 95% CI [-0.854, 0.434], p = 0.522), HDL (SMD = 0.157, 95% CI [-0.36, 0.674], p = 0.551), triglycerides (SMD = -0.041, 95% CI [-0.461, 0.38], p = 0.849), or glucose (SMD = -0.071, 95% CI [-0.213, 0.071], p = 0.326). Heterogeneity was moderate to high. Conclusions. Exercise interventions did not significantly improve metabolic syndrome components in SMI. Future trials must prioritize tailored regimens, adjunctive therapies, and rigorous control of medication effects., Prof. Mikel Izquierdo was supported in part by “Proyectos de I + D + i”» de los Programas Estatales de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I + D + i Orientada a los Retos de la Sociedad, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017–2020 (PID2020-113098RB-I00) and by the European Union and Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (AEI), Unión Europea NextGenerationEU/PRTR with number PLEC2021-0080171 and by EU Funded H2020-DIABFRAIL-LATAM (H2020-SC1-BHC-825546).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Moderation effect of handgrip strength on cognition and functional independence associations in adults over 90 years

  • López Sáez de Asteasu, Mikel
  • Lusa Cadore, Eduardo
  • Steffens, Tainara
  • Blanco‑Rambo, Eduarda
  • Molinari, Talita
  • Guimarães, Marcelo Bandeira
  • Izquierdo Redín, Mikel
  • Pietta-Dias, Caroline
Introduction: The causal relationship between cognitive impairment and functional decline seems bidirectional in older adults. This study aimed to determine the moderating effect of handgrip strength on the relationship between cognition and functional independence among Brazilian nonagenarians and centenarians. Methods: A cross-sectional study was performed on 150 older adults aged > 90 years (141 nonagenarians and nine centenarians). A total of 105 participants (70%) were female. Cognitive function was assessed using the Mini-Mental State Examination (MMSE), and functional independence was evaluated using the Katz Index score. The maximal isometric grip strength was measured using a handgrip dynamometer. A moderation analysis was performed to test whether handgrip strength moderated the association between cognition and functional independence, stratified by biological sex and adjusted for body weight. Results: Handgrip strength moderated the relationship between cognition and functional independence in both male and female older adults (p < 0.05). When handgrip strength was < 24.40 kg for males (42% of the study sample) and < 17.30 kg for female participants (60% of the study sample), the influence of cognitive function on functional independence was significant. Conclusion: Handgrip strength moderates the relationship between cognition and functional independence in Brazilian nonagenarians and centenarians. This attenuating effect of muscle strength on the impact of cognitive function on functional independence was observed in both weaker male and female individuals. Longitudinal studies are needed to validate our findings, as the cross-sectional design limits the causal inferences., This work was supported by the National Council for Scientific and Technological Development (CNPq, Brazil) and Coordination for the Improvement of Higher Educational Personnel (CAPES, Brazil). Prof. Mikel Izquierdo was supported in part by «Proyectos de I + D + i» de los Programas Estatales de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I + D + i Orientada a los Retos de la Sociedad, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (PID2020-113098RB-I00) and by the European Union and Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (AEI), Unión Europea NextGenerationEU/PRTR with number PLEC2021-0080171 and by EU Funded H2020-DIABFRAIL-LATAM (H2020-SC1-BHC-825546).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Integrating exercise and medication management in geriatric care: a holistic strategy to enhance health outcomes and reduce polypharmacy

  • Izquierdo Redín, Mikel
  • Ramírez Vélez, Robinson
  • Fiatarone Singh, Maria
Integrating exercise prescriptions with medication management represents a novel approach for enhancing health and function, optimising medication effectiveness, and reducing adverse drug reactions and polypharmacy in older adults (ie, those aged ≥60 years). This Personal View highlights the need for a comprehensive assessment of lifestyle, diagnoses, geriatric syndromes, and medications with an emphasis on fully incorporating exercise treatment into geriatric care. Exercise is an alternative to less effective or unsafe medications for many conditions, including depression, anxiety, insomnia, osteoarthritis, and dementia. Exercise is an important adjunct to pharmacotherapy for many common chronic conditions such as coronary artery disease, heart failure, diabetes, osteoporosis, cancer, and chronic obstructive pulmonary disease. Adding exercise to drug management can mitigate adverse drug reactions, enhance medication compliance, and reduce the adverse effects of sedentary behaviour and ageing processes on chronic disease expression. Targeted exercise programmes have also been shown to ameliorate drug-induced side-effects, including anorexia, falls, sarcopenia, osteoporosis, and orthostatic hypotension, and to overcome constraints such as reduced aerobic fitness, balance impairment, and muscle atrophy due to some medications. Health-care professionals require additional training and support to ensure that exercise assumes a key, central role in older adults with multimorbidity and polypharmacy, as supported by the current literature. This Personal View describes practical approaches to incorporating exercise into clinical practice as a step towards an integrated geriatric care model, with the ultimate aim of increasing health span and minimising disability., Mi was supported in part by Proyectos de I+D+i de los Programas Estatales de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i Orientada a los Retos de la Sociedad, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-20 (PID2020-113098RB-I00), the EU and Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, Unión Europea Next GenerationEU/ PRTR (PLEC2021-0080171), and by the EU-funded H2020-DIABFRAIL-LATAM (H2020-SC1-BHC-825546).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Effectiveness of post-discharge exercise interventions in older adults following acute hospitalisation: a systematic review and meta-analysis

  • Etayo Urtasun, Paula
  • Izquierdo Redín, Mikel
  • López Sáez de Asteasu, Mikel
Background: acute hospitalisation is a recognised risk factor for adverse outcomes in older adults, including hospital-associated disability. Post-discharge exercise interventions might mitigate physical and cognitive decline, although the few meta-analyses performed previously present limitations. This systematic review and meta-analysis aimed to evaluate the effect of post-discharge exercise interventions on health-related outcomes in older adults. Methods: a systematic search of PubMed, Scopus, Web of Science, and ScienceDirect was conducted following PRISMA 2020 guidelines on May 16, 2025. Randomised controlled trials published from Jan 1, 2000, to May 16, 2025, were included. These studies assessed the effectiveness of muscular strength and endurance exercises in older adults (aged 60 years and older) discharged from acute hospitalisation. There were no language filters. Two reviewers independently screened studies using the PICOS framework, extracted data from published reports, and assessed methodological quality using the Physiotherapy Evidence Database scale. Data were pooled using a random-effects model. This systematic review and meta-analysis is registered with PROSPERO, CRD42025630147. Findings: the search yielded 2868 results, of which 17 articles (1458 participants) met inclusion criteria, with a mean Physiotherapy Evidence Database score of 7·3 (SD 0·9) out of 10, indicating moderate to high quality. Post-discharge exercise significantly improved physical function (standardised mean difference [SMD] 0·78 [95% CI 0·52 to 1·05], p<0·0001). No significant effects were observed for health-related quality of life (SMD 0·23 [−0·04 to 0·51], p=0·098) or readmission risk (risk ratio 0·64 [95% CI 0·39 to 1·05], p=0·076). Exercise effects on functional independence, cognitive function, frailty, and mortality were synthesised descriptively due to insufficient data for meta-analysis. The main sources of heterogeneity were the outcome assessment tools and the exercise protocols. No evidence of risk of bias was found using either selection models (p>0·05) or Egger’s test (p>0·05) for any of the outcomes. Interpretation: post-discharge exercise interventions are effective at improving physical function in older adults following acute hospitalisation; however, effects on other health-related outcomes remain inconclusive. Future studies should establish optimal post-discharge exercise modalities, dosages, and delivery strategies tailored to individual patient needs. Advancing these priorities could improve patient outcomes and health-care system efficiency., MI was supported in part by R&D&I Projects of the State Programme for Knowledge Generation and Scientific and Technological Strengthening of the R&D&I System, within the framework of the Spanish State Plan for Scientific and Technical Research and Innovation 2017-20 (PID2020-113098RBI00); and by the EU Ministry of Science and Innovation NextGenerationEU Recovery, Transformation and Resilience Plan (PLEC2021-0080171) and Horizon 2020 Diabetes and Frailty in LatinAmerica Project (H2020-SC1-BHC-825546).